Overview
BDNF is the primary neurotrophin supporting neuronal survival, synaptic plasticity, and memory formation in the hippocampus and prefrontal cortex. Reduced BDNF is a consistent finding in depression, schizophrenia, and neurodegeneration. The gut microbiome modulates BDNF through butyrate-mediated HDAC inhibition and vagal nerve signaling.
Microbiome → BDNF Pathway
- butyrate crosses the blood-brain barrier and acts as an HDAC inhibitor, directly upregulating BDNF gene transcription in the hippocampus [1].
- Germ-free mice show reduced hippocampal BDNF — colonization with commensals restores it.
- Probiotic supplementation (Bifidobacterium, Lactobacillus) increases serum BDNF in clinical trials [2].
- Gut microbiome composition correlates with dopamine, serotonin, and BDNF levels in schizophrenia [3].
- Hashimoto's-associated neuroinflammation reduces BDNF in mouse models [4].
Clinical Relevance
- Depression: Reduced BDNF is the most replicated biomarker; antidepressant efficacy correlates with BDNF restoration.
- Schizophrenia: Reduced in prefrontal cortex; probiotics increase BDNF but do not significantly improve PANSS scores in early trials [2].
- Exercise: Physical activity increases BDNF via both direct neuronal stimulation AND microbiome-mediated butyrate production.
Cross-References
- butyrate — HDAC inhibitor that upregulates BDNF transcription
- gut brain axis — BDNF as microbiome-modulated neurotrophic mediator
- serotonin — BDNF and serotonin have reciprocal regulatory relationships
- depression — reduced BDNF as core biomarker
- neuroinflammation — inflammation reduces BDNF